Competition for lab space threatens Kendall Square’s innovative spark.
12
Jun2015
Comments Off on Start-ups fight for a place in Boston’s biotech hub – Nature.com
June 2015
2015
"We want findings that can change the world."
12
Jun2015
Comments Off on China is quickly gaining a competitive edge in biotech
Genomic Vision sélectionnée dans le projet BeyondSeq Horizon 2020 d’une dotation globale de 6 M€ – France Biotech
at News - by Admin
L'association a pour but de promouvoir le développement de l’industrie des biotechnologies et des sciences de la vie en France
11
Jun2015
Comments Off on Genomic Vision sélectionnée dans le projet BeyondSeq Horizon 2020 d’une dotation globale de 6 M€ – France Biotech
Cellectis présente ses résultats financiers pour le premier trimestre 2015 – France Biotech
at News - by Admin
"Cellectis (Alternext : ALCLS – Nasdaq Global Market : CLLS), se met en conformité avec les pratiques de communication financière du NASDAQ en publiant pour la première fois ses résultats pour le 1er trimestre 2015."
11
Jun2015
Comments Off on Cellectis présente ses résultats financiers pour le premier trimestre 2015 – France Biotech
Just 8 months after gathering together a $12 million A round to get started with its own twist on adaptive T-cell technology, Cambridge, MA-based Unum Therapeutics has teamed up with Seattle Genetics in a $645 million immuno-oncology deal designed to marry some finely tuned antibody drug conjugate technology with the latest in cancer-fighting R&
10
Jun2015
Comments Off on Seattle Genetics conjugates with immuno-oncology upstart Unum in $645M deal
Clarus Ventures announced this morning that it had raised $500 million for its third biotech fund, Clarus III, easily beating its goal of $375 million.
10
Jun2015
Comments Off on Clarus adds a $500M biotech venture fund as the good times roll
Actelion flambe avec la rumeur
09
Jun2015
Comments Off on Shire : vers une OPA géante sur Actelion dans les biotechnologies ?
Montbleu Terra chez Montbleu Finance est un fonds flexible qui peut être exposé de 0 à 100% aux marchés d'actions, ou de 0 à 100% aux marchés de ...
09
Jun2015
Comments Off on OPCVM : le compartiment des biotechnologies en soutien…
Massachusetts General Hospital Launches Phase 2 Trial of BCG Vaccine to Reverse Type 1 Diabetes
at Uncategorized - by Admin
A phase 2 clinical trial testing the ability of the generic vaccine bacillus Calmette-Guérin (BCG) to reverse advanced type 1 diabetes has received approval from the U.S. Food and Drug Administration (FDA).
09
Jun2015
Comments Off on Massachusetts General Hospital Launches Phase 2 Trial of BCG Vaccine to Reverse Type 1 Diabetes
Mayo Clinic’s hometown wants to be a $6.5B biotech hub
at News - by Admin
Rochester, MN, home of the Mayo Clinic, is an otherwise unassuming Midwestern city, housing about 111,000 people on the Zumbro River. But the town's leaders have a plan to transform it into a global hub of biotech research and cutting-edge medical technology, approving a $6.5 billion plan that will remake Rochester over the next 20 years.
08
Jun2015
Comments Off on Mayo Clinic’s hometown wants to be a $6.5B biotech hub
June 2015